Tocagen Archives -

A phase 3 trial of Tocagen’s therapy for high-grade glioma (HGG) – a form of brain cancer –

Tocagen plummets on phase 3 data for glioma therapy

https://pharmaphorum.com/news/tocagen-plummets-on-phase-3-data-for-glioma-therapy/

An early-stage drug candidate for hard-to-treat brain tumours has been granted special ‘PRIME’ status by the European Medicines

Tocagen’s brain tumour candidate gets PRIME designation

https://pharmaphorum.com/news/tocagens-brain-tumour-treatment-gets-prime-designation/

Brain cancer specialist Tocagen is to become the latest biotech to test the waters with an IPO this

Tocagen aims for IPO to fund brain cancer trial

https://pharmaphorum.com/news/tocagen-aims-ipo-fund-brain-cancer-trial/

Tocagen